Cargando…
Preclinical tissue distribution and metabolic correlations of vigabatrin, an antiepileptic drug associated with potential use‐limiting visual field defects
Vigabatrin (VGB; (S)‐(+)/(R)‐(‐) 4‐aminohex‐5‐enoic acid), an antiepileptic irreversibly inactivating GABA transaminase (GABA‐T), manifests use‐limiting ocular toxicity. Hypothesizing that the active S enantiomer of VGB would preferentially accumulate in eye and visual cortex (VC) as one potential m...
Autores principales: | Walters, Dana C., Jansen, Erwin E. W., Ainslie, Garrett R., Salomons, Gajja S., Brown, Madalyn N., Schmidt, Michelle A., Roullet, Jean‐Baptiste, Gibson, K. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321982/ https://www.ncbi.nlm.nih.gov/pubmed/30631446 http://dx.doi.org/10.1002/prp2.456 |
Ejemplares similares
-
Torin 1 partially corrects vigabatrin-induced mitochondrial increase in mouse
por: Vogel, Kara R, et al.
Publicado: (2015) -
In vitro modeling of experimental succinic semialdehyde dehydrogenase deficiency (SSADHD) using brain-derived neural stem cells
por: Vogel, Kara R., et al.
Publicado: (2017) -
Vigabatrin-Induced Retinal Functional Alterations and Second-Order Neuron Plasticity in C57BL/6J Mice
por: Chan, Kore, et al.
Publicado: (2020) -
Longitudinal metabolomics in dried bloodspots yields profiles informing newborn screening for succinic semialdehyde dehydrogenase deficiency
por: Brown, Madalyn, et al.
Publicado: (2020) -
Vigabatrin and Visual Field Defects in Pediatric Epilepsy Patients
por: You, Su Jeong, et al.
Publicado: (2006)